textabstractBackground: The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure of the cardiac right ventricle. It has long been hypothesized that during the development of chronic cardiac failure the heart becomes energy deprived, possibly due to shortage of oxygen at the level of cardiomyocyte mitochondria. However, direct evaluation of oxygen tension levels within the in vivo right ventricle during PAH is currently lacking. Here we directly evaluated this hypothesis by using a recently reported technique of oxygen-dependent quenching of delayed fluorescence of mitochondrial protoprophyrin IX, to determine the distribution of mitochondrial oxygen tension (mitoPO2) within the right ventricle (RV) subjected to...
Right ventricular failure (RVF) remains the leading cause of death in pulmonary arterial hypertensio...
Background: Pulmonary arterial hypertension (PAH) is a fatal disease; however, the mechanisms direct...
Background In complex congenital heart disease patients such as those with tetralogy of Fallot, the ...
Background: The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure o...
Background: The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure o...
Objective: Reactive oxygen species (ROS) have been implicated in the progression of ventricular hype...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Background In complex congenital heart disease patients such as those with tetralogy of Fallot, the ...
Item does not contain fulltextAIMS: In cardiac hypertrophy (CH) and heart failure (HF), alterations ...
Pulmonary arterial hypertension (PAH) results in hypertrophic remodeling of the right ventricle (RV)...
Right ventricular failure (RVF) remains the leading cause of death in pulmonary arterial hypertensio...
Background: Pulmonary arterial hypertension (PAH) is a fatal disease; however, the mechanisms direct...
Background In complex congenital heart disease patients such as those with tetralogy of Fallot, the ...
Background: The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure o...
Background: The leading cause of mortality due to pulmonary arterial hypertension (PAH) is failure o...
Objective: Reactive oxygen species (ROS) have been implicated in the progression of ventricular hype...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Introduction: Group 2 pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure ≥25...
Background In complex congenital heart disease patients such as those with tetralogy of Fallot, the ...
Item does not contain fulltextAIMS: In cardiac hypertrophy (CH) and heart failure (HF), alterations ...
Pulmonary arterial hypertension (PAH) results in hypertrophic remodeling of the right ventricle (RV)...
Right ventricular failure (RVF) remains the leading cause of death in pulmonary arterial hypertensio...
Background: Pulmonary arterial hypertension (PAH) is a fatal disease; however, the mechanisms direct...
Background In complex congenital heart disease patients such as those with tetralogy of Fallot, the ...